PAUL LEE: Open Payments
NPI 1144996745 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 28 payments from 14 companies in 2025. Trend: 2023 $854 · 2024 $1,224 · 2025 $805
Food & beverage: $669Education: $136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| ACCORD HEALTHCARE, INC. | 1 | $120 |
| Sumitomo Pharma America, Inc. | 4 | $104 |
| Janssen Biotech, Inc. | 2 | $93 |
| Astellas Pharma US Inc | 2 | $92 |
| IMMUNITYBIO, INC. | 2 | $52 |
| PFIZER INC. | 2 | $47 |
| UROGEN PHARMA, INC. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $25 |
Products named: LUPRON DEPOT, Camcevi, ERLEADA, GEMTESA, XTANDI, ANKTIVA, Nubeqa, LithoVue.
Industry payments across CA — which companies pay providers there.
